We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Study Finds Cost of Drug-Coated Stents Outweighs Their Relative Benefits
Study Finds Cost of Drug-Coated Stents Outweighs Their Relative Benefits
September 9, 2005
The benefits of drug-coated stents don’t justify the increased cost over traditional bare-metal stents, according to a recent study that recommends the devices be restricted to patients in high-risk groups.